Brind.

Nektar Therapeutics is headquartered in San Francisco and its pipeline includes a modified CSF protein.

1 report, 0 independent Updated Jun 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

CSF Nektar Therapeutics San Francisco

Keep exploring

The entities involved

CSF
- Takeda presented clinical data at the United European Gastroenterology (UEG) meeting on October 19, 2026.Mon 10:16
Nektar Therapeutics
American healthcare company
- Nektar Therapeutics' board granted stock options to new employees on October 23, 2026.Fri 22:38
San Francisco
consolidated city and county in California, United States
- Sebastian Thrun predicts widespread adoption of autonomous vehicles in Singapore, suggesting AV economics will favor Singapore over San Francisco.Fri 10:30
- Federal authorities began targeting immigrants across California.Fri 06:48

Related events

Leerink Partners assumed coverage on Nektar Therapeutics shares on October 13, 2026.Oct 13

Coverage

Newest first; wire copies grouped

Jun 24Unknown outlet